(Q38349063)

2 September 2017

1 reference

title

The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy (English)

1 reference

2 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gordon Wallace

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Eva Tomaskovic-Crook

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Jeremy Micah Crook

1

1 reference

2 September 2017

Gordon Wallace

2

1 reference

2 September 2017

Eva Tomaskovic-Crook

3

1 reference

2 September 2017

9 February 2015

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

295-304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

Reprogramming cellular identity for regenerative medicine

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Synaptic dysregulation in a human iPS cell model of mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Enhancing induced pluripotent stem cell models of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modelling schizophrenia using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling psychiatric disorders at the cellular and network levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Deficits in human trisomy 21 iPSCs and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Trisomy correction in Down syndrome induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The Roots of Autism and ADHD Twin Study in Sweden (RATSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Great expectations: autism spectrum disorder and induced pluripotent stem cell technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Signaling defects in iPSC-derived fragile X premutation neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling epilepsy with pluripotent human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

A human Dravet syndrome model from patient induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Familial Alzheimer's disease modelling using induced pluripotent stem cell technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

[Modeling familial Alzheimer's disease with induced pluripotent stem cells].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Solving the puzzle of Parkinson's disease using induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling Parkinson's disease using induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Using stem cells and iPS cells to discover new treatments for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Cellular reprogramming: a new approach to modelling Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Redefining Parkinson's disease research using induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling Huntington's disease with induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Long-term self-renewable feeder-free human induced pluripotent stem cell-derived neural progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Improved reproducibility by assuring confidence in measurements in biomedical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

A method for efficiently generating neurospheres from human-induced pluripotent stem cells using microsphere arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Technological overview of iPS induction from human adult somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Routes to induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The generation of six clinical-grade human embryonic stem cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Feeder-independent culture of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Derivation of human embryonic stem cells in defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Chemically defined conditions for human iPSC derivation and culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Cellular mechanisms of direct-current electric field effects: galvanotaxis and metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Electrical fields in wound healing-An overriding signal that directs cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Environmental magnetic fields: influences on early embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The responses of cells to electrical fields: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Nanotopographical cues augment mesenchymal differentiation of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Confined 3D microenvironment regulates early differentiation in human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Attachment and growth of human embryonic stem cells on microcarriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Materials as stem cell regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Carbon nanotube composites as multifunctional substrates for in situ actuation of differentiation of human neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Bioprinting of artificial blood vessels: current approaches towards a demanding goal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Developmental neurotoxicity: some old and new issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Neurotoxicity testing: a discussion of in vitro alternatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1013096

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE10821

Identifiers

DOI

10.1586/14737175.2015.1013096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664599%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference